These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38944653)

  • 1. Biomarkers of mortality in adults and adolescents with advanced HIV in sub-Saharan Africa.
    Riitho V; Connon R; Gwela A; Namusanje J; Nhema R; Siika A; Bwakura-Dangarembizi M; Musiime V; Berkley JA; Szubert AJ; Gibb DM; Walker AS; Klein N; Prendergast AJ
    Nat Commun; 2024 Jun; 15(1):5492. PubMed ID: 38944653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced Prophylaxis plus Antiretroviral Therapy for Advanced HIV Infection in Africa.
    Hakim J; Musiime V; Szubert AJ; Mallewa J; Siika A; Agutu C; Walker S; Pett SL; Bwakura-Dangarembizi M; Lugemwa A; Kaunda S; Karoney M; Musoro G; Kabahenda S; Nathoo K; Maitland K; Griffiths A; Thomason MJ; Kityo C; Mugyenyi P; Prendergast AJ; Walker AS; Gibb DM;
    N Engl J Med; 2017 Jul; 377(3):233-245. PubMed ID: 28723333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Causes and Timing of Mortality and Morbidity Among Late Presenters Starting Antiretroviral Therapy in the REALITY Trial.
    Post FA; Szubert AJ; Prendergast AJ; Johnston V; Lyall H; Fitzgerald F; Musiime V; Musoro G; Chepkorir P; Agutu C; Mallewa J; Rajapakse C; Wilkes H; Hakim J; Mugyenyi P; Walker AS; Gibb DM; Pett SL;
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S132-S139. PubMed ID: 29514234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognosis of patients with HIV-1 infection starting antiretroviral therapy in sub-Saharan Africa: a collaborative analysis of scale-up programmes.
    May M; Boulle A; Phiri S; Messou E; Myer L; Wood R; Keiser O; Sterne JA; Dabis F; Egger M;
    Lancet; 2010 Aug; 376(9739):449-57. PubMed ID: 20638120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of ready-to-use supplementary food on mortality in severely immunocompromised HIV-infected individuals in Africa initiating antiretroviral therapy (REALITY): an open-label, parallel-group, randomised controlled trial.
    Mallewa J; Szubert AJ; Mugyenyi P; Chidziva E; Thomason MJ; Chepkorir P; Abongomera G; Baleeta K; Etyang A; Warambwa C; Melly B; Mudzingwa S; Kelly C; Agutu C; Wilkes H; Nkomani S; Musiime V; Lugemwa A; Pett SL; Bwakura-Dangarembizi M; Prendergast AJ; Gibb DM; Walker AS; Berkley JA;
    Lancet HIV; 2018 May; 5(5):e231-e240. PubMed ID: 29653915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial.
    Siika A; McCabe L; Bwakura-Dangarembizi M; Kityo C; Mallewa J; Berkley J; Maitland K; Griffiths A; Baleeta K; Mudzingwa S; Abach J; Nathoo K; Thomason MJ; Prendergast AJ; Walker AS; Gibb DM;
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S140-S146. PubMed ID: 29514235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Priorities for Decreasing Morbidity and Mortality in Children With Advanced HIV Disease.
    Frigati L; Archary M; Rabie H; Penazzato M; Ford N
    Clin Infect Dis; 2018 Mar; 66(suppl_2):S147-S151. PubMed ID: 29514237
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raltegravir-intensified initial antiretroviral therapy in advanced HIV disease in Africa: A randomised controlled trial.
    Kityo C; Szubert AJ; Siika A; Heyderman R; Bwakura-Dangarembizi M; Lugemwa A; Mwaringa S; Griffiths A; Nkanya I; Kabahenda S; Wachira S; Musoro G; Rajapakse C; Etyang T; Abach J; Spyer MJ; Wavamunno P; Nyondo-Mipando L; Chidziva E; Nathoo K; Klein N; Hakim J; Gibb DM; Walker AS; Pett SL;
    PLoS Med; 2018 Dec; 15(12):e1002706. PubMed ID: 30513108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Survival, clinical and biological outcomes of HIV-infected children treated by antiretroviral therapy in Africa: systematic review, 2004-2009].
    Ndondoki C; Dabis F; Namale L; Becquet R; Ekouevi D; Bosse-Amani C; Arrivé E; Leroy V
    Presse Med; 2011; 40(7-8):e338-57. PubMed ID: 21295437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contemporary issues on the epidemiology and antiretroviral adherence of HIV-infected adolescents in sub-Saharan Africa: a narrative review.
    Adejumo OA; Malee KM; Ryscavage P; Hunter SJ; Taiwo BO
    J Int AIDS Soc; 2015; 18(1):20049. PubMed ID: 26385853
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retention and mortality on antiretroviral therapy in sub-Saharan Africa: collaborative analyses of HIV treatment programmes.
    Haas AD; Zaniewski E; Anderegg N; Ford N; Fox MP; Vinikoor M; Dabis F; Nash D; Sinayobye JD; Niyongabo T; Tanon A; Poda A; Adedimeji AA; Edmonds A; Davies MA; Egger M;
    J Int AIDS Soc; 2018 Feb; 21(2):. PubMed ID: 29479867
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The incidence rate of tuberculosis and its associated factors among HIV-positive persons in Sub-Saharan Africa: a systematic review and meta-analysis.
    Wondmeneh TG; Mekonnen AT
    BMC Infect Dis; 2023 Sep; 23(1):613. PubMed ID: 37723415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Boosted protease inhibitor monotherapy versus boosted protease inhibitor plus lamivudine dual therapy as second-line maintenance treatment for HIV-1-infected patients in sub-Saharan Africa (ANRS12 286/MOBIDIP): a multicentre, randomised, parallel, open-label, superiority trial.
    Ciaffi L; Koulla-Shiro S; Sawadogo AB; Ndour CT; Eymard-Duvernay S; Mbouyap PR; Ayangma L; Zoungrana J; Gueye NFN; Diallo M; Izard S; Bado G; Kane CT; Aghokeng AF; Peeters M; Girard PM; Le Moing V; Reynes J; Delaporte E;
    Lancet HIV; 2017 Sep; 4(9):e384-e392. PubMed ID: 28566227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early immunologic failure is associated with early mortality among advanced HIV-infected adults initiating antiretroviral therapy with active tuberculosis.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Makutu DK; Nfanyana K; Rantleru T; Tierney A; Nkakana K; Schwartz AB; Gross R; Macgregor RR; Bellamy SL; Frank I; Weissman D; Bisson GP
    J Infect Dis; 2013 Dec; 208(11):1784-93. PubMed ID: 23908475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric Access and Continuity of HIV Care Before the Start of Antiretroviral Therapy in Sub-Saharan Africa.
    Bastard M; Poulet E; Nicolay N; Szumilin E; Balkan S; Pujades-Rodriguez M
    Pediatr Infect Dis J; 2016 Sep; 35(9):981-6. PubMed ID: 27187757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and factors associated with viral non-suppression in people living with HIV receiving antiretroviral therapy in sub-Saharan Africa: A systematic review and meta-analysis.
    Mosha IH; Nyondo GG; Munishi CG; Njiro BJ; Bwire GM
    Rev Med Virol; 2024 May; 34(3):e2540. PubMed ID: 38708846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Anti-inflammatory Effects of Cotrimoxazole Prophylaxis for People Living With Human Immunodeficiency Virus in Sub-Saharan Africa.
    Bourke CD; Prendergast AJ
    J Infect Dis; 2020 Jul; 222(3):347-350. PubMed ID: 31714953
    [No Abstract]   [Full Text] [Related]  

  • 18. Causes and determinants of mortality in HIV-infected adults with tuberculosis: an analysis from the CAMELIA ANRS 1295-CIPRA KH001 randomized trial.
    Marcy O; Laureillard D; Madec Y; Chan S; Mayaud C; Borand L; Prak N; Kim C; Lak KK; Hak C; Dim B; Sok T; Delfraissy JF; Goldfeld AE; Blanc FX;
    Clin Infect Dis; 2014 Aug; 59(3):435-45. PubMed ID: 24759827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa.
    Boender TS; Hoenderboom BM; Sigaloff KC; Hamers RL; Wellington M; Shamu T; Siwale M; Labib Maksimos EE; Nankya I; Kityo CM; Adeyemo TA; Akanmu AS; Mandaliya K; Botes ME; Ondoa P; Rinke de Wit TF
    Clin Infect Dis; 2015 Dec; 61(11):1749-58. PubMed ID: 26240203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
    Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
    Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.